John M Cruickshank

Summary

Publications

  1. ncbi request reprint Beta-blockers and heart failure
    John M Cruickshank
    Independent Cardiovascular Consultant, Long Melford, Great Britain
    Indian Heart J 62:101-10. 2010
  2. ncbi request reprint Are we misunderstanding beta-blockers
    J M Cruickshank
    Cambridge University, Long Melford, Suffolk CO10 9DE, United Kingdom
    Int J Cardiol 120:10-27. 2007
  3. ncbi request reprint The J-curve in hypertension
    John Cruickshank
    42 Harefield, Long Melford, Suffolk CO10 9DE, United Kingdom
    Curr Cardiol Rep 5:441-52. 2003
  4. ncbi request reprint Antihypertensive treatment and the J-curve
    J M Cruickshank
    Oxonian Cardiovascular Consultancy, Long Melford, Suffolk, UK
    Cardiovasc Drugs Ther 14:373-9. 2000
  5. ncbi request reprint Beta-blockers and diabetes: the bad guys come good
    John Malcolm Cruickshank
    Cardiovasc Drugs Ther 16:457-70. 2002
  6. ncbi request reprint Losartan for cardiovascular disease in patient's with and without diabetes in the LIFE study
    John Malcolm Cruickshank
    Lancet 359:2200-1; author reply 2203-4. 2002

Detail Information

Publications6

  1. ncbi request reprint Beta-blockers and heart failure
    John M Cruickshank
    Independent Cardiovascular Consultant, Long Melford, Great Britain
    Indian Heart J 62:101-10. 2010
    ..Lipophilic BB like propranolol and metoprolol appear in high concentrations in human brain tissue and are associated with side-effects such as insomnia, dreams and nightmares...
  2. ncbi request reprint Are we misunderstanding beta-blockers
    J M Cruickshank
    Cambridge University, Long Melford, Suffolk CO10 9DE, United Kingdom
    Int J Cardiol 120:10-27. 2007
    ..Hypertensives (of all ages) with ischaemia are well suited to beta-blockade...
  3. ncbi request reprint The J-curve in hypertension
    John Cruickshank
    42 Harefield, Long Melford, Suffolk CO10 9DE, United Kingdom
    Curr Cardiol Rep 5:441-52. 2003
    ..In such high-risk (for myocardial infarction) cases it would be prudent to avoid lowering DBP to below the low 80s mm Hg...
  4. ncbi request reprint Antihypertensive treatment and the J-curve
    J M Cruickshank
    Oxonian Cardiovascular Consultancy, Long Melford, Suffolk, UK
    Cardiovasc Drugs Ther 14:373-9. 2000
    ..In contrast, ischemic hypertensives should not have their DBP lowered to less than the mid- to low 80s for fear of increasing the risk of MI...
  5. ncbi request reprint Beta-blockers and diabetes: the bad guys come good
    John Malcolm Cruickshank
    Cardiovasc Drugs Ther 16:457-70. 2002
    ..g. reducing risk of bronchoconstriction, is achieved by choosing an agent with high beta-1 selectivity...
  6. ncbi request reprint Losartan for cardiovascular disease in patient's with and without diabetes in the LIFE study
    John Malcolm Cruickshank
    Lancet 359:2200-1; author reply 2203-4. 2002